Meza-Carmona J, Corona-Perezgrovas MA, Rivera-Navarrete E, Fagoaga-Valdivia J, Olguín-Sánchez CR, Corona-López F

Language: English
References: 7
Page: 174-178
PDF size: 2437.73 Kb.

ABSTRACT

The HeartMate 3 left ventricular assist device represents an established therapeutic option of therapy in advanced heart failure. We describe our institutional implantation technique, incorporating three key modifications: a double-ring apical reinforcement system with biological adhesive to optimize hemostasis, a “C”-shaped driveline tunneling technique as an anti-infectious barrier, and transesophageal echocardiography-guided inflow cannula positioning to ensure optimal alignment toward the mitral valve.

REFERENCES

1. Mehra MR, Uriel N, Naka Y, et al. A fully magnetically levitatedleft ventricular assist device - final report. N Engl J Med. 2019;380(17):1618-1627. doi: 10.1056/NEJMoa1900486.

2. Gosev I, Pham DT, Um JY, et al. Ventricular assist device using athoracotomy-based implant technique: Multi-Center Implantationof the HeartMate 3 in subjects with heart failure using surgicaltechniques other than full median sternotomy (HM3 SWIFT). JThorac Cardiovasc Surg. 2024;168(5):1474-1484.e12. doi: 10.1016/j.jtcvs.2024.02.013.

3. Imamura T, Narang N, Nitta D, et al. Optimal cannula positioningof HeartMate 3 left ventricular assist device. Artif Organs.2020;44(12):e509-e519. doi: 10.1111/aor.13755.

4. Netuka I. HeartMate 3 left ventricular assist system implantationtechnique: the devil is in the detail. Interact Cardiovasc Thorac Surg.2018;27(6):946-949. doi: 10.1093/icvts/ivy264.

5. Wert L, Hanke JS, Dogan G, et al. Reduction of driveline infectionsthrough doubled driveline tunneling of left ventricular assist devices— 5-year follow-up. J Thorac Dis. 2018;10(Suppl 15):S1703-S1710.doi: 10.21037/jtd.2018.03.127.

6. Johnson CA, Melvin AL, Robinson DA, Amirjamshidi H, KnightPA, Gosev I. Titanium fastener utilization during HeartMate 3left ventricular assist device implantation. Innovations (Phila).2018;13(5):361-364. doi: 10.1097/IMI.0000000000000560.

7. Mehra MR, Cleveland JC Jr, Uriel N, et al. Primary results of longtermoutcomes in the MOMENTUM 3 pivotal trial and continuedaccess protocol study phase: a study of 2200 HeartMate 3 leftventricular assist device implants. Eur J Heart Fail. 2021;23(8):1392-1400. doi: 10.1002/ejhf.2211.